Cell and Gene Therapies: Meeting the Challenge of Faster Batch Release
Whereas traditional small-molecule programs have 18 to 48 months until product expiry, cell and gene therapy products could have just 72 hours. Ed Taylor shares strategies to speed up batch release, optimize quality processes, and reinforce the strategic role of quality as a partner to the business.








